FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer

Saturday, August 27th, 2011

The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has ...

Protein Discovery Could Lead To A Diagnostic Test For Lung Cancer And Development Of Drugs That Stop Metastasis

Friday, March 4th, 2011

Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ...

Limitations To Ultrasound In The Detection And Measurement Of Urinary Tract Calculi

Tuesday, August 3rd, 2010

UroToday.com - Urinary tract stones are commonly diagnosed and followed by ultrasound (US). Our study highlights several important limitations to the test that should be recognized by the clinician. First, compared with axial unenhanced CT, stone size tends to be overestimated, particularly when � 10mm. This finding illustrates the danger ...

Could A Diagnostic Blood Test Be Created For Depression?

Sunday, July 25th, 2010

Psychiatry, unlike many other areas of medicine, lacks diagnostic blood tests. Blood tests have been extremely useful in helping doctors make medical diagnoses and aiding them in treatment options for conditions and diseases in most medical fields. An article in Biological Psychiatry reports that Dutch researchers may eventually generate blood ...

Abbott Receives FDA Clearance For New Ovarian Cancer Test

Friday, June 4th, 2010

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test ...